Home
Orbimed Advisors reported a 13.9% stake in Q32 Bio QTTB · 4,127,987 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 13.9%
- Last report
- 17.4% · filed 26/06/01
- Shares held
- 4,127,987 sh
- Class
- COMMON STOCK
- Stock
- Q32 Bio QTTB
- Holder
- Orbimed Advisors
- Event date
- 26/07/16
- Filed
- 26/07/20
13.9% stake · −3.5pp from the last report
- Stake
- 13.9%
- Last report
- 17.4%
- Since last report
- −3.5pp
Q32 Bio trades, last 26 weeks
What else happened in Q32 Bio around then
Filed or reported within 30 days of the trade day · 06/16~08/15Orbimed Advisors's other 5% stake reports
- Orbimed Advisors
5% stakeElectra Therapeutics
5% stakeElectra Therapeutics
ETRA
11% stake
6,885,170 sh
11% stake
Filed 09/25
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
13.5% stake
12,175,159 sh
13.5% stake
Filed 09/10
- Orbimed Advisors
5% stakeBraveheart Bio
5% stakeBraveheart Bio
BRVE
17.2% stake
12,175,159 sh
17.2% stake
Filed 08/18
- Orbimed Advisors
5% stakeBlossomHill Therapeutics
5% stakeBlossomHill Therapeutics
BLSM
8.9% stake
2,714,279 sh
8.9% stake
Filed 08/18
- Orbimed Advisors
5% stakeWhitehawk Therapeutics
5% stakeWhitehawk Therapeutics
WHWK
7.3% stake
3,934,296 sh
7.3% stake
Filed 08/14
